Renaissance Technologies’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.8K | Buy |
36,300
+600
| +2% | +$558 | ﹤0.01% | 3429 |
|
|
2025
Q1 | $34.7K | Buy |
35,700
+600
| +2% | +$584 | ﹤0.01% | 3325 |
|
|
2024
Q4 | $42.4K | Buy |
35,100
+7,200
| +26% | +$8.7K | ﹤0.01% | 3411 |
|
|
2024
Q3 | $33.2K | Buy |
27,900
+2,800
| +11% | +$3.33K | ﹤0.01% | 3389 |
|
|
2024
Q2 | $35.1K | Sell |
25,100
-2,600
| -9% | -$3.64K | ﹤0.01% | 3324 |
|
|
2024
Q1 | $66K | Sell |
27,700
-1,999
| -7% | -$4.76K | ﹤0.01% | 3441 |
|
|
2023
Q4 | $110K | Buy |
29,699
+8,299
| +39% | +$30.7K | ﹤0.01% | 3282 |
|
|
2023
Q3 | $66K | Sell |
21,400
-12,600
| -37% | -$38.9K | ﹤0.01% | 3341 |
|
|
2023
Q2 | $70K | Buy |
34,000
+22,600
| +198% | +$46.5K | ﹤0.01% | 3549 |
|
|
2023
Q1 | $26K | Buy |
+11,400
| New | +$26K | ﹤0.01% | 3779 |
|